| Primary |
| Crohn's Disease |
11.1% |
| Conjunctivitis |
8.3% |
| Corneal Abscess |
8.3% |
| Eye Infection |
8.3% |
| Foreign Body In Eye |
8.3% |
| Ischaemic Stroke |
8.3% |
| Eye Injury |
5.6% |
| Purulent Discharge |
5.6% |
| Ulcerative Keratitis |
5.6% |
| Antifungal Treatment |
2.8% |
| Bacterial Pyelonephritis |
2.8% |
| Cataract Operation |
2.8% |
| Corneal Abrasion |
2.8% |
| Eye Inflammation |
2.8% |
| Glaucoma |
2.8% |
| Nasopharyngitis |
2.8% |
| Neuropathy Peripheral |
2.8% |
| Postoperative Care |
2.8% |
| Prophylaxis |
2.8% |
| Thrombosis Prophylaxis |
2.8% |
|
| Ocular Hyperaemia |
8.7% |
| Toxic Skin Eruption |
8.7% |
| Wheezing |
8.7% |
| Alopecia Areata |
4.3% |
| Conjunctival Hyperaemia |
4.3% |
| Corneal Graft Rejection |
4.3% |
| Drug Ineffective |
4.3% |
| Drug Reaction With Eosinophilia And Systemic Symptoms |
4.3% |
| Dyspnoea |
4.3% |
| Eye Swelling |
4.3% |
| Eyelid Oedema |
4.3% |
| Febrile Convulsion |
4.3% |
| Feeling Abnormal |
4.3% |
| Hypopyon |
4.3% |
| Iritis |
4.3% |
| Medication Error |
4.3% |
| Mouth Ulceration |
4.3% |
| Muscle Spasms |
4.3% |
| Ophthalmia Neonatorum |
4.3% |
| Petit Mal Epilepsy |
4.3% |
|
| Secondary |
| Drug Use For Unknown Indication |
17.9% |
| Keratitis Bacterial |
12.6% |
| Crohn's Disease |
11.6% |
| Ischaemic Stroke |
8.4% |
| Ear Infection |
7.4% |
| Foreign Body In Eye |
6.3% |
| Product Used For Unknown Indication |
4.2% |
| Thrombosis Prophylaxis |
4.2% |
| Bacterial Pyelonephritis |
3.2% |
| Conjunctivitis |
3.2% |
| Neuropathy Peripheral |
3.2% |
| Conjunctivitis Infective |
2.1% |
| Erysipelas |
2.1% |
| Intraocular Lens Implant |
2.1% |
| Macular Degeneration |
2.1% |
| Pain |
2.1% |
| Ulcerative Keratitis |
2.1% |
| Venous Insufficiency |
2.1% |
| Viral Infection |
2.1% |
| Acne |
1.1% |
|
| Toxic Skin Eruption |
20.0% |
| Febrile Convulsion |
15.0% |
| Drug Ineffective |
10.0% |
| Rash Morbilliform |
10.0% |
| Drug Reaction With Eosinophilia And Systemic Symptoms |
5.0% |
| Hepatocellular Injury |
5.0% |
| Hypoacusis |
5.0% |
| Incorrect Route Of Drug Administration |
5.0% |
| Mouth Ulceration |
5.0% |
| Post Procedural Complication |
5.0% |
| Stevens-johnson Syndrome |
5.0% |
| Vertigo |
5.0% |
| Visual Acuity Reduced |
5.0% |
|
| Concomitant |
| Drug Use For Unknown Indication |
17.4% |
| Product Used For Unknown Indication |
17.4% |
| Breast Cancer |
7.4% |
| Conjunctivitis |
5.5% |
| Pain |
4.9% |
| Sleep Apnoea Syndrome |
4.9% |
| Injury Corneal |
4.4% |
| Postoperative Wound Infection |
4.2% |
| Ulcerative Keratitis |
4.2% |
| Bronchitis |
3.8% |
| Prophylaxis |
3.6% |
| Bone Density Decreased |
3.2% |
| Crohn's Disease |
2.8% |
| Acute Sinusitis |
2.5% |
| Gastric Ulcer |
2.5% |
| Multiple Myeloma |
2.5% |
| Type 2 Diabetes Mellitus |
2.5% |
| Depression |
2.3% |
| Anxiety |
2.1% |
| Hypertension |
1.7% |
|
| Weight Increased |
19.5% |
| Pneumonia |
13.4% |
| Vomiting |
7.3% |
| Wound Secretion |
7.3% |
| Bile Duct Cancer |
4.9% |
| Thrombocytopenia |
4.9% |
| Toxic Skin Eruption |
4.9% |
| Vertigo |
4.9% |
| Arteriosclerosis |
3.7% |
| Intestinal Dilatation |
3.7% |
| Squamous Cell Carcinoma Of Skin |
3.7% |
| Coronary Artery Thrombosis |
2.4% |
| Intervertebral Disc Protrusion |
2.4% |
| Neutropenia |
2.4% |
| Obesity |
2.4% |
| Pancreatic Carcinoma |
2.4% |
| Sepsis |
2.4% |
| Skin Toxicity |
2.4% |
| Tachycardia |
2.4% |
| Ventricular Tachycardia |
2.4% |
|
